AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Battalion Oil today, you need to believe the company can turn a highly volatile share price and an unprofitable business into something more durable by using fresh capital and a cleaner balance sheet. The new US$15,000,000 private placement, on top of roughly US$60,000,000 of recent asset sale proceeds and debt repayment, gives Battalion more breathing room around its NYSE compliance plan and ongoing operating needs, but it does not remove the core risks. Short term, the main catalysts remain execution on its expanded gas processing agreement and any further steps to strengthen liquidity, now supported by this raise. On the risk side, negative free cash flow, ongoing dilution from repeated capital issuances and the potential resale of new shares and prefunded warrants all feel more pressing after a very large price move.
However, the recent capital raise also brings fresh dilution and resale overhang that investors should understand. Our expertly prepared valuation report on Battalion Oil implies its share price may be too high.Explore 2 other fair value estimates on Battalion Oil - why the stock might be worth less than half the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com